Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca reports decline in Q4 profits, to slash 7,600 jobs
The company posted net sales of $8.19 billion in the fourth quarter of 2008, a marginal increase, compared to $8.17 billion posted in the corresponding period of 2007.
The company posted net sales of $8.19 billion in the fourth quarter of 2008, a marginal increase, compared to $8.17 billion posted in the corresponding period of 2007.
Dr Sparks said: “Canyon Gate Medical Group holds a great vision for healthcare in Las Vegas. This new partnership will allow our patients to have one location for
Under the terms of this financing, investments will be made in three tranches: $8 million before March 31, 2009, $8 million before December 31, 2009 and $8 million
In addition, approximately $3.2 million of outstanding indebtedness and accrued interest due to an affiliate of Piramal was assumed by RxElite Holdings and is no longer an obligation
Mr Tremmel has almost 30 years of leadership experience as an executive at Medtronic, where he oversaw the successful design, development and commercial launch of a number of
Seattle Genetics intends to use the net proceeds from this offering to fund research and development, including clinical trials and manufacturing campaigns for its proprietary product candidates, and
According to the company, the two cladribine tablet treatment groups of the study, assessing different dose regimens, demonstrated a statistically significant reduction in the annualized rate of relapses
The newly patented method uses cMyc-ER, a recombinant fusion of two proteins normally present in cells, c-Myc, a human cell-cycle regulating protein, and estrogen receptor (ER), a human
These designations are in addition to the SGN-35 orphan drug designation for Hodgkin lymphoma previously received from the FDA. The company plans to initiate a pivotal trial of
In addition to the 24 countries where SenoRx products are already being sold, the company will begin marketing EnCor, its vacuum-assisted breast biopsy product, and its GelMark line